Cengild Medical Berhad (0243) — Capital Reinvestment Ratio
Cengild Medical Berhad (0243) has a Capital Reinvestment Ratio of 39.05x as of December 2025, meaning it reinvests 39% of its operating cash flow (RM947.00K) in capital expenditures (RM36.98 Million). Check 0243 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cengild Medical Berhad Capital Reinvestment Ratio (2020–2025)
This chart tracks Cengild Medical Berhad's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 0243 cash generation efficiency.
Annual Capital Reinvestment Ratio for Cengild Medical Berhad (2020–2025)
Year-by-year Capital Reinvestment Ratio for Cengild Medical Berhad from 2020 to 2025. See Cengild Medical Berhad free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.32x | RM16.08 Million | RM37.26 Million | ▲ +90.5% |
| 2024 | 1.22x | RM12.94 Million | RM15.73 Million | ▲ +686.2% |
| 2023 | 0.15x | RM13.76 Million | RM2.13 Million | ▲ +408.4% |
| 2022 | 0.03x | RM14.05 Million | RM427.67K | ▼ -74.4% |
| 2021 | 0.12x | RM14.30 Million | RM1.70 Million | ▲ +118.8% |
| 2020 | 0.05x | RM11.24 Million | RM610.08K | — |